[Improvement of bioavailability of menaquinone-4 by dimethyl-beta-cyclodextrin complexation following oral administration]. 1988

Y Horiuchi, and M Kikuchi, and F Hirayama, and K Uekama, and M Ueno, and T Ijitsu

UI MeSH Term Description Entries
D008297 Male Males
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D003505 Cyclodextrins A homologous group of cyclic GLUCANS consisting of alpha-1,4 bound glucose units obtained by the action of cyclodextrin glucanotransferase on starch or similar substrates. The enzyme is produced by certain species of Bacillus. Cyclodextrins form inclusion complexes with a wide variety of substances. Cycloamylose,Cyclodextrin,Cyclodextrin Derivatives,Cyclomaltooligosaccharides,Derivatives, Cyclodextrin
D003912 Dextrins A group of low-molecular-weight carbohydrates produced by the hydrolysis of STARCH or GLYCOGEN. They are mixtures of polymers of D-glucose units linked by alpha-(1->4) or alpha-(1->6) glycosidic bonds. Dextrin
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

Y Horiuchi, and M Kikuchi, and F Hirayama, and K Uekama, and M Ueno, and T Ijitsu
February 1983, Journal of pharmacobio-dynamics,
Y Horiuchi, and M Kikuchi, and F Hirayama, and K Uekama, and M Ueno, and T Ijitsu
November 1983, Journal of pharmaceutical sciences,
Y Horiuchi, and M Kikuchi, and F Hirayama, and K Uekama, and M Ueno, and T Ijitsu
January 2000, Pharmaceutical development and technology,
Y Horiuchi, and M Kikuchi, and F Hirayama, and K Uekama, and M Ueno, and T Ijitsu
January 1995, Pharmacological research,
Y Horiuchi, and M Kikuchi, and F Hirayama, and K Uekama, and M Ueno, and T Ijitsu
September 1980, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Y Horiuchi, and M Kikuchi, and F Hirayama, and K Uekama, and M Ueno, and T Ijitsu
April 1981, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Y Horiuchi, and M Kikuchi, and F Hirayama, and K Uekama, and M Ueno, and T Ijitsu
June 1991, The Journal of pharmacy and pharmacology,
Y Horiuchi, and M Kikuchi, and F Hirayama, and K Uekama, and M Ueno, and T Ijitsu
January 2013, Biological & pharmaceutical bulletin,
Y Horiuchi, and M Kikuchi, and F Hirayama, and K Uekama, and M Ueno, and T Ijitsu
June 1998, Drug development and industrial pharmacy,
Y Horiuchi, and M Kikuchi, and F Hirayama, and K Uekama, and M Ueno, and T Ijitsu
January 1992, Acta pharmaceutica Nordica,
Copied contents to your clipboard!